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Keratinocytes, a key cellular component both for homeosta-
sis and pathophysiologic processes of the skin, secrete a num-
ber of cytokines and are stimulated by several growth factors. 
Nerve growth factor (NGF) is synthesized in the skin and 
basal keratinocytes express the low-affinity nerve growth 
factor receptor (NGF-R). We present evidence that normal 
human keratinocytes in culture express the low- and the 
high-affinity NGF-R both at the mRNA level, as determined 
by reverse-transcription polymerase chain reaction and at the 
protein level, as shown by cytofluorimetric analysis. NGF 
significantly stimulates the proliferation of normal human 
keratinocytes in culture in a dose-dependent manner. This 
effect can be prevented by the addition of both an anti-NGF 
N erve growth factor (NGF) is a neurotrophic protein that plays a crucial role in the development and maintenance of sensory and sympathetic neurons [1]. NGF is retrogradely transported from target tissues and nerve terminals to neuronal cell bodies 
and also exerts neurotropic properties for some primary neural 
crest-derived sensory neurons, peripheral adrenergic, and central 
cholinergic neurons [2]. 
There is increasing evidence that NGF, in addition to its actions 
within the nervous system, possesses a number of biologic effects on 
cells of the immune-inflammatory compartment. Specifically, 
NGF increases the number of mast cells in rats [3], causes a massive 
degranulation of rat peritoneal mast cells [4,5], promotes myeloid 
progenitor cell growth [6], induces proliferation and differentiation 
of human B lymphocytes [7] , and profoundly modulates human 
basophil mediator release [8] . Furthermore, NGF induces interleu-
kin 1 (IL-1) expression in PC12 pheochromocytoma cells [9], as it 
suppresses leukotriene C4 production by human eosinophils [10]. 
Keratinocytes, the most numerous cells in the epidermis, ·are 
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neutralizing antibody and a high-affinity NGF-R (trk) spe-
cific inhibitor, the natural alkaloid K252a. By contrast, kerat-
inocyte proliferation is not inhibited by an anti -low-affinity 
NGF-R monoclonal antibody, thus suggesting that NGF 
effect on human keratinocytes is mediated by the high-affin-
ity NGF-R. Moreover, NGF mRNA is expressed in normal 
human keratinocytes and NGF is secreted by keratinocytes in 
increasing amounts during growth, as detected by enzyme-
linked immunosorbent assay. These results suggest that NGF 
could act as a cytokine in human skin and take part in disor-
ders of keratinocyte proliferation. Key words: trk/polymerase 
chain reaction/proliferation/ELISA/ secretion. ] Invest Dermato! 
103:13-18,1994 
thought to be crucial to cutaneous inflammatory responses [11] . 
Indeed, they produce a variety of mediators such as eicosanoids [12] 
and cytokines [13], and proliferate in response to different factors 
[14]. Among others, hormonal and neural substances have been 
shown to control cell growth. Bovine pituitary extract (BPE) is 
usually added to culture to increase the proliferation of keratino-
cytes [15] and prolactin, a hormone of the anterior pituitary gland, 
has been recently demonstrated to stimulate keratinocyte growth 
[16]. In addition, the neuropeptide vasoactive intestinal polypeptide 
is mitogenic for human keratinocytes ill vitro [17,18] and substance 
P stimulates the proliferation of Pam 212 cells [19]. 
NGF synthesis has been shown in developing mouse skin, begin-
ning with sensory innervation [20], and NGF messenger RNA 
(mRNA) is expressed by human keratinocytes in vitro [21,22]. 
Moreover, NGF-receptor (NGF-R) has recently been demonstrated 
by immunohistochemistry in normal human skin and NGF-R im-
munoreactive nerve terminals have been shown in contact with 
basal keratinocytes [23]. Two classes of NGF-R have been identi-
fied, a low-affinity receptor of -75 kd (p75) and a high-affinity 
receptor of -140 kd (p140) [24,25]. This latter has been recently 
found to be the proto-oncogene trk (p140 trk). Human trk proto-
oncogene encodes a 140-kd tyrosine kinase with the structural 
characteristics of a growth factor receptor [26]. Trk gene is ex-
pressed prominently in sensory neurons of spinal ganglia and in the 
portion of sensory neurons of cranial ganglia that originates from 
neural crest [27]. NGF specifically stimulates tyrosine autophos-
phorylation of p140 trk in PC12 cells, in spinal ganglia sensory 
neurons, and in NIH 3T3 cells transfected with trk eDNA [28,29]. 
In the present study, we report that normal human keratinocytes 
express both the low- and the high-affin.ity NGF-R. Furthermore, 
NGF stimulates the proliferation. of human keratinocytes in culture, 
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Table I. Oligodeoxynucleotides Used in the RT-PCR Reaction 
Oligomer" Nucleotide sequence (5'-3') Region Reference 
NGF-R DP 
NGF-RRP 
NGF-R rev pr 
trk DP 
trk RP 
trk rev pr 
NGFDP 
NGFRP 
NGF rev pr 
p-Actin DP 
p-Actin RP 
p-Actin rev pr 
TGAGTGCTGCAAAGCCTGCAA 
TCTCATCCTGGTAGTAGCCGT 
TCACCACGTCGGAGAACGTCACGCTGTCCAGGCAG 
GGCTCCTCGGGACTGCGATG 
CAGGAGAGAGACTCCAGAGCG 
GCCACGAAACGGAGACCACTCTTCACGATGGTG 
TCATCATCCCATCCCATCTT 
CTTGACAAAGGTGTGAGTCG 
ACTGTTTGAATACACTGTTGTTAATGTTCACCTCTCCCAA 
TGGATGATGATATCGCCGCGCTCG 
CACATAGGAATCCTTCTGACCCA 
AGGGGAAGACGGCCCGGGGGGCATCGTCGCCCG 
236-256 
445-465 
311-345 
214-233 
459-479 
372-404 
9496-9515 
9740-9759 
9610-9649 
75-98 
213-235 
138-170 
[24] 
[26] 
[32] 
[33] 
• DP, direct primer~ RP, reverse primer; Rev pr, reverse probe. 
whereas the trk specific inhibitor K252a prevents this effect. Fi-
nally, we show that keratinocytes synthesize and secrete NGF. 
MATERIALS AND METHODS 
Keratinocyte Cultivation Keratinocyte cultures were prepared as de-
scribed [18]. Briefly, keratinocytes for primary cultures were obtained from 
skin plastic surgery. Skin was minced and trypsinized (0.05% trypsin, 0.02% 
ethylenediaminetetraacetic acid [EDTA]) at 37 ' C for 3 hand keratinocytes 
were grown in 75-cm2 culture flasks (Costar, Cambridge, MA) with mito-
mycin-treated (10 mg/ml for 2 h at 37 ' C [Sigma, St. Louis, MO]) 3T3 cel ls. 
Cells were cultured in Dulbecco's modified Eagle's medium/Ham's F12 
medium (DMEM/F12, 3 : 1) (Seromed-Biochrom KG, Berlin, Germany) 
containing insulin (5 I-lg/ml, Sigma), transferrin (5 I-lg/ml, Sigma), triiodo-
thyronine (2 nM, Sigma), hydrocortisone (0.4 Jlg/ml, Sigma), adenine (180 
mM, Sigma), mouse epidermal growth factor (EGF, 10 ng/ml, Sigma), and 
10% fetal bovine serum (FBS) (Seromed-Biochrom) . Subconfluent primary 
cultures were passaged in secondary cultures as described [18]. FBS was 
removed from the medium in all the experiments. The K562 cell line has 
been grown in RPMI 1640 medium supplemented with 20% FBS, 2 mML 
glutamine, and 40% Iscove's. PC12 cell line was a kind gift from FIDIA 
S.p.a. (Abano Terme, Italy). 
RNA Purification and RQl Digestion RNA was purified using a 
modified guanidinium/cesium chloride centrifugation method as described 
[30]. Briefly, keratinocytes from secondary cultures were subcultivated in 
DMEM/F12, as described above, until near confluence. Cells were then 
lysed in 4 M guanidinium thiocyanate, and the lysates were extracted by 
ultracentrifugation through a cesium chloride cushion (5.7 M CsCl, 0.1 
EOTA, pH 7) . The RNAs were then recovered, extracted once with phenol-
chloroform, precipitated with ethanol, and resuspended in sterile bidistilled 
water. To further purify the RNAs, to avoid genomic DNA contamination, 
samples were digested with RQ1 (Promega, Madison, WI) as described [31]. 
The RNAs were then extracted, precipitated, and resuspended in sterile 
bidistilled water containing 200 U /ml RNAse inhibitor (RNAsin, Promega, 
Madison, WI) . 
Oligonucletides Primers and Probes Oligonucletides primers and 
probes were synthesized on an automatic solid-phase synthesizer (Applied 
Biosystems, Inc., Mod 381 A, Foster City, CAl by standard phosphoramidite 
chemistry and purified by several extractions with NH.OH, followed by 
incubation at 56' C for at least 16 h, and concentrated by ethanol precipita-
tion or polyacrylamidc gel e1cctrophoresis (31]' Table I lists the sequences of 
the synthesized oligomers and their relationship to the organization of the 
cONAs regarding the low-affinity NGF-R, the high-affinity NGF-R, 
NGFp, and P actin [24,26,32,33]. Computer analysis, performed to compare 
the synthesized oligomers to the human sequences in the gene bank data base 
(Hitachi Software Engineering America Ltd., San Bruno, CAl, revealed no 
more than 70% homology among all the other genes. Oligodeoxynucleo-
tides (200 ng) were labeled using standard procedures [34]. Specific radio-
activities ranged from 1 to 3 X 10· cpm/Jlg DNA. 
Reverse Transcription-Polymerase Chain Reaction (RT-PCR) and 
Southern Blotting The reactions were carried out using a modification 
of the technique described (35). Briefly, 1 I-lg of total cellular RNA extracted 
from 30 X 106 cel ls was reverse-transcribed using 400 U of M-MuLV re-
verse-transcriptase (GIBCO BRL, Life Technologies Inc., Gaithersburg, 
MO) and 1 I-lg of OligodT 15 primer (Boehringer, Mannheim, Germany) 
for 1 hand 30 min at 37 ' C in 1 X eDNA buffer (10 mM Tris-HCL, pH 8.3, 
50 mM KC1, 2 mM MgCl2 , 10 mM dithiothreitol, and 200 JlM dATP, 
dCPT, dGPT, and dTTP). The resulting specific cDNA fragments were 
amplified with 2.5 U ofTaq polymerase (Promega) in the presence of 0.5 I-lg 
direct primer (DP), 0.5 Jlg reverse primer (RP), both specific for the RNAs 
examined, and 1 X eDNA buffer. DNA fragments corresponding to the 
different genes studied were generated during 40 cycles of PCR (denatura-
tion at 94 ' C for 1 min, annealing for 2 min at temperatures ranging from 
40'C to 55'C, depending on the base composition of the different primers, 
and extension at 72 ' C for 4 min). Twenty-five microliters of the PCR 
reaction mixture (50 ml total volume reaction) were separated on a 2% 
agarose gel, denatured in 0.2 N NaOH, 0.6 M NaCI for 45 min, neutralized 
in 25 mM phosphate buffer (pH 6.5) for 45 min, and electroblotted onto a 
Gene-Screen membrane (NEN, Boston, MA) fixed by UV cross-linking (0.6 
Joules/cm2 , 312 nm). Blots were hybridized with labeled oligodeoxynu-
cleotide probes as described [36] and autoradiography performed under stan-
dard conditions. To evaluate the amount of RNA in each sample, the P actin 
mRNA was amplified by RT -PCR with an optimized number of 25 cycles. 
For each sample studied several negative controls were performed, as de-
tailed in the Fig 1 legend. Each experiment was carried out at least three 
times. 
Indirect Immunofluorescence Subconfluent keratinocytes from sec-
ondary cultures, cultivated as described above, were harvested using a tryp-
sin/EOTA solution for 15 min and washed. Cell suspensions were fixed 
with a 2% paraformaldehyde solution w /wo 0.5% Triton XI00 (Sigma) for 
10 min and rinsed in RPMI plus 10% FBS. Cells were incubated with a 
monoclonal antibody (MoAb) directed against p75 NGF-R (1 : 50) (Amer-
sham, Buckinghamshire, England) and a polyclonal antibody against p140 
trk NGF-R (epitope corresponding to amino acids 777 - 790 within the 
carboxy terminus, 1: 50, Santa Cruz Biotechnology, CAl for 1 h at 4' C. 
Cells were then incubated with biotinylated horse anti-mouse IgG (Vector, 
CA, diluted 1 : 30) or with biotinylated goat anti-rabbit IgG (Vector, diluted 
1 : 30) for 45 min at 4 ' c. Finally, cells were incubated with streptavidin-
fluorescein (Amersham, 1 : 50) for 30 min at 4' C and rinsed in RPMI plus 
10% FBS. Cells were then washed again, resuspended in cold phosphate-
buffered saline, and analyzed by an argon-equipped flow cytometer (FAC-
SCAN, Becton Dickinson, San Jose, CAl. A minimum of 10,000 cells per 
sample was acquired in list mode by electronically gating the region of cells 
with physical characteristic of keratinocytes. Controls were performed by 
replacing the primary antibody with irrelevant mouse or rabbit sera. Cells 
were also incubated with anti - S-l 00 antibody to rule out the possibility of 
melanocyte contamination. 
Cell Proliferation Assay Keratinocytes (1 X 104 per well) were culti-
vated on 3T3 cells (3 X 104 per well) in triplicate on 24-well plates (2 cm' 
per well, Costar) in DMEM/F12 serum-free medium containing 0.1 % bo-
vine serum albumin (BSA) (Boehringer), EGF, and various concentrations of 
NGFp (Boehringer) (10, 100,500 ng/ml). In control experiments, kerati-
nocyte cultures were established as above, w /wo the addition of an excess or 
allti-NGF neutralizing MoAb (Boehringer), or equal concentrations of an 
isotype-matched control antibody. Keratinocytes were also pretreated with 
the natural alcaloid K252a (100 nM, Sigma) or with an anti-p75 MoAb, 
Medium containing EGF, without the addition ofNGF, has been referred tG 
as control medium. Media were changed every second day. KeratinocytC\ 
were harvested by using a trypsin/EDT A solution for 15 min and counted i ~ 
an automatic cell counter (Coulter Electronics Ltd., Luton, England). Re, 
suits are expressed as means ± SEM and Student t test was used for compari, 
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Figure 1. Detection of the low-affinity NGF-R mRNA expression by 
RT-PCR and Southern blot analysis. Upper panel: the autoradiogram of the 
NGF-R mRNA obtained after Southern analysis is illustrated. Total cellu-
lar RNA extraction from the different cell populations as well as RT -PCR 
experimental conditions are detailed in Materials and Methods and the oli-
gomers used are reported in Table I. Cell populations and controls are as 
follows: lane 1, human keratinocytes; lane 2, murine fibroblasts; lane 3, 
PC12 cell line (positive control); lane 4, genomic DNA derived from 
healthy donor leukocytes, amplified under the same experimental condi-
tions to exclude possible DNA contamination; lane 5, PCR amplification 
performed on total cellular RNA without reverse transcription; lane 6, 
negative control performed under the same experimental conditions with-
out any template to exclude cross-contamination. Lower panel: p actin 
mRNA expression has been used as a quantitative control of RNA. 
son of the means. Results were obtained from three independent experi-
ments. 
Enzyme-Linked lmmunosorbent Assay (ELISA) Assay for NGF 
Keratinocytes were subcultivated in serum-free DMEM/F12 with EGF and 
0.1 % BSA. Culture-conditioned media were collected at different times of 
incubation and, after centrifugation, stored at - 20· C until used. The NGF 
content was measured using a rwo-site ELISA specific for human NGF, 
which has been previously described [37). Culture-conditioned media from 
feeder layer fibroblasts (3T3) were collected as a control. Results are ex-
pressed as the mean from three independent experiments. 
RESULTS 
Detection ofNGF-R on Normal Human Keratinocytes The 
RT-PCR data obtained from the study of the low-affinity NGF-R 
mRNAare shown in Fig 1. A single band of expected size (230 bp) is 
observed in lane 1 corresponding to human keratinocytes, demon-
strating that these cells express the low-affinity NGF-R at the 
mRNA level. PC12 cells expressing the low-affinity NGF-R 
mRNA were used as a positive control (Fig 1, lane 3). In addition, 
RT-PCR analysis for trk mRNA expression shows a single band of 
the expected size (266 bp), which hybridizes with the specific probe 
after Southern blot analysis (Fig 2, lane 1). The same amplified 
fragment of 266 bp is clearly detectable in K562 cell line that has 
been used as a positive control (Fig 2, lane 2). Negative controls are 
listed in the legends of Figs 1 and 2. Particularly, the RT -PCR of an 
equivalent quantity of total RNA from murine fibroblasts (3T3) 
fails to show any amplified fragment both for the low-affinity 
NGF-R and trk (Fig 1, lane 2 and Fig 2, lane 3), demonstrating that 
the signal observed in human keratinocytes is not due to contami-
nating feeder layer cells. As a control for the amount of RNA in the 
samples, specific oligomers for the p actin mRNA [33] were used in 
a parallel amplification reaction generating an amplified fragment 
o~161 bp. Negative controls, performed as detailed in the legends of 
Figs 1 and 2 (lanes 4 - 6), show that neither the specific gene studied 
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Figure 2. Autoradiogram of the trk (high-affinity NGF-R) mRNA expres-
sion by RT-PCR and Southern blot analysis. The size of the amplified 
fragment and the cell populations studied are illustrated. Cell populations 
and controls are as follows: lalle 1, human keratinocytes; lalle 2, K562 cell 
line (positive control); lane 3, murine fibroblasts; lanes 4- 6 represent the 
same controls as described in Fig 1. In the lower pallel, the p-actin mRNA 
expression, used as a quantitative control, is reported. 
nor the P actin amplified fragments are detectable. These results 
clearly demonstrate that human keratinocytes express both the low-
and the high-affinity NGF-R at the mRNA level. 
Indirect Immunofluorescence Cytofluorimetric analysis on 
subconfluent keratinocytes was performed to demonstrate the pres-
ence of the low- and the high-affinity NGF-R at the protein level. 
Figure 3 shows that nearly all keratinocytes express both p75 and 
p140 NGF-R. As illustrated in A, with anti-p75 MoAb, most cells 
display high fluorescence intensity. On the other hand, p140 (B), 
although expressed on most of the cells, shows a much weaker 
intensity. No staining was observed with irrelevant mouse or rabbit 
sera and no immunoreactivity was detected using anti-S-100 anti-
body (data not shown). 
Effect ofNGF on Keratinocytes To evaluate whether NGF-Rs 
on keratinocyte are functional, the effect of NGF on keratinocyte 
proliferation was examined. Keratinocytes from secondary cultures 
were grown in DMEM serum-free medium containing 0.1 % BSA, 
EGF, and NGFp (10, 100, and 500 ng/ml). NGFp significantly 
stimulated the proliferation of keratinocytes in a dose-dependent 
fashion (Figs 4 and 5). The specificity of NGF effect on human 
keratinocytes was assessed by the addition of an excess of anti-NGF 
neutralizing MoAb that caused a significant reduction of NGF-in-
duced proliferation (Fig 4). The addition of an isotype-matched 
control antibody did not affect keratinocyte growth (data not 
shown). To examine the role of p75 and p140 trk NGF-R, the 
anti-p75 MoAb or the natural alcaloid K252a were added to culture 
medium. K252a selectively inhibits NGF-induced trk proto-onco-
gene tyrosine phosphorilation [38], thus blocking the high-affinity 
NGF-R, whereas anti-p75 inhibits NGF binding to the low-affinity 
NGF-R. Figure 5 shows that K252a dramatically inhibits NGF-in-
duced keratinocyte proliferation at all concentrations used. The 
addition of K252a in absence of NGF did not exert any effect on 
keratinocyte proliferation (Fig 5), indicating that inhibition is not 
due to cytotoxicity. On the other hand, anti-p75 MoAb could not 
affect NGF activity on keratinocytes (data not shown). 
Detection ofNGF in Normal Human Keratinocytes Using 
sequence-specific NGFp primers (Table I), samples of reverse-tran-
scribed keratinocyte RNA show a single band of the predicted size 
16 PINCELLI ET AL 
IA 
) 
B 
,\\ 
l \ 
I \ ~ )1 
I 
I 
I 
FLUORESCENCE INTENSITY 
Figure 3. Cytofluorimetric analysis of the expression of the low-affinity 
NGF-R (A) and the high-affinity NGF-R (B) on keratinocytcs. Subcon-
fluent keratinocytes were harvested using a trypsin/EDTA solution and 
stained as detailed in Materials afld Methods . A minimum of 10,000 cells per 
sample was acquired in list mode by electronically gating the region of cells 
with physical characteristic of keratinocytes. Keratinocytes were incubated 
with a mouse MoAb directed against p75 (A) or a rabbit polyclonal Ab to 
p140 (B) . Controls were obtained by replacing the primaty antibody with 
irrelevant mouse (A) or rabbit (B) sera. 
(264 bp) that specifically hybridizes with the corresponding probe 
after Southern blot analysis (Fig 6, lane 1). The negative result in Fig 
6, lane 2 rules out the possibility that NGF expression in keratino-
cyte cultures originates from contaminating murine 3T3 fibro-
450 
400 
I 350 j 300 
# 250 
i 200 
E 150 ~ 
t:: 100 ~ 50 
0 
0 1 0 1 0 0 500 
NGF (ng/ml) 
Figure 4. Effect of NGF on the proliferation of cultured human keratino-
cytes. Keratinocytes were cultivated in DMEM/F12 serum-free medium 
containing 0.1 % BSA, EGF, and various concentrations of NGF,B (hatc/led 
bars) w /wo the addition of anti-NGF neutralizing MoAb (solid bars) . Kerati-
nocyte growth with EGF alone corresponds to 100 on the y axis. Data are 
expressed as means ± SEM of triplicate cultures from five independent ex-
periments. Student t tcst was used for comparison of the means. NGFjJ (500, 
100 ng/ml) versus control (EGF alone), p < 0.001. NGF,B (10 ng/ml) 
versus control, p < 0.01. NGF,B (500 ng/ml) versus NGF,B + anti-NGF 
MoAb, p < 0.05. 
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Figure 5. Effect of K252a on NGF-induced keratinocyte proliferation. 
Keratinocytes were cultivated in DMEM/F12 serum-free medium contain-
ing 0.1 % BSA, EGF, and various concentrations of NGFp (hatched bars), 
wjwo the addition of K252a (solid bars). Keratinocyte growth with EGF 
alone corresponds to 100 on the y axis. Data are expressed as means ± SEM 
of triplicate cultures from live independent experiments. Student t test was 
used for comparison of the means. NGFjJ (500, laO, 10 ng/ml) versus 
control (EGF alone), p < 0.001. NGF,B (500, 100 ng/ml) versus NGF + 
K252a, p < 0.001. NGF,B (10 ng/ml) versus NGF + K252a, p < 0.002. 
blasts. A sample of keratinocyte mRNA that was not reverse tran-
scribed but was otherwise processed identically to the sample in lane 
1 fails to show any specific band, thus confirming that the NGF 
band comes from keratinocyte mRNA and not from contaminating 
genomic DNA (Fig 6, lane 3). Figure 6, lane 4 shows a negative 
control performed in the same experimental conditions without any 
template. OUf data confirm that human keratinocytes express 
NGFp at the mRNA level. 
ELISA To determine NGF levels in keratinocyte conditioned 
medium, 1 X 104 and 1 X 105 cells per well were seeded. In both 
ffj 
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Figure 6. Autoradiogram of the NGFp mRNA expression by RT-PCR an, 
Southern blot analysis. A strong band of the predicted size (264 bp) is sec\ 
after 50 cycles (lalle 1). The different control lanes are explained in the texI 
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Figure 7. NGFp levels secreted by normal human keratinocytes, measured 
by ELISA. 10,000 (open bars) or 100,000 (solid bars) cells were cultivated in 
DMEM/F12 on 3T3 cells and culture supernatants collected at different 
times after seeding. NGF levels are given in pg/ml and results are expressed 
as means ± SEM of triplicate from three independent experiments. 
types of cultures, NGF was detected in the conditioned media after 
the first day of incubation. NGF levels increased from day 1 to day 5 
after seeding proportionally to the different cell number. At day 7, 
when cells reach the confluence, NGF levels dramatically decreased 
through day 13 (Fig 7), thus indicating that confluent keratinocytes 
secrete lower levels of NGF as compared to growing cells. To fur-
ther confirm this observation, at day 7, a smaller number of seeded 
keratinocytes, which at this time are still growing, produced greater 
NGF concentrations than did a higher cell number already at con-
fluence . From day 8 through day 13, all cells have reached the 
confluence despite the seeding number and secrete equal amounts of 
NGF. NGF was undetectable in culture supernatants from murine 
fibroblasts (3T3) . 
DISCUSSION 
This study demonstrates that human keratinocytes in culture ex-
press both the low- and the high-affinity receptors mRNA species 
for NGF and also display a proliferative response to this factor. 
Thus, non-neuronal cells such as human keratinocytes can, like 
neurons, co-express both NGF receptor classes. However, unlike 
neuronal cells, the exposure of human keratinocytes to NGF results 
in a proliferative rather than a differentiative response. This poses 
important questions concerning relationships between structural-
functional properties of the receptors and the cascade of intracellular 
events involved in mediating the different physiologic response to 
NGF. 
Recent work has demonstrated that expression of the trk proto-
oncogene is, at least in PC12 cells or primary neurons, critical for 
NGF signal transduction [29,39,40]. Much uncertainty exists, 
however, concerning the functional role of the p75 receptor com-
ponent. Although some have suggested that p140 trk alone may 
constitute the high-affinity NGF receptor [41], and p75 the low-af-
finity NGF binding sites [42], others have proposed that both recep-
tor components are individually low-affinity receptors, the co-ex-
pression and consequent association being necessary for the 
generation of high-affinity binding sites [29]. Data suggesting that 
the binding of NGF can convert the low-affinity to the high-affin-
ity receptors [43] and/or that the NGF receptor components may 
perhaps not interact directly at the level of the receptors themselves 
[44] could, in part, account for these discrepancies. Despite reports 
of the expression of similar receptors alone or in combination on 
cultured Schwann cells or glial cells, respectively [45], and ofNGF 
effects on other cells such as melanocytes [22] and lymphocytes [7], 
the exact nature and functional requirements of the receptors un-
derlying the NGF effects in non-neural cells have yet to be fully 
defined. 
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Results in this paper support the concept that keratinocytes also 
have the potential of co-expressing p140 trk and p75 NGF-R com-
ponents. As tyrosine kinase activation is a common feature in the 
proliferative responses to many growth factors [46]' the occurrence 
of the trk proto-oncogene in human keratinocytes suggests that this 
receptor component may be important for the proliferative action of 
NGF on these cells. Trk has been associated with induction of DNA 
synthesis in variant NIH 3T3 cells when stimulated with NGF [47] . 
Because the p75 protein lacks tyrosine kinase activity, this receptor 
component may not be required for the proliferative action ofNGF 
in human keratinocytes. Indeed, the results presented in this paper 
seem to confirm that NGF effect on keratinocyte proliferation can 
be exerted through the p140 trk high-affinity NGF-R, whereas 
blocking p75 protein is irrelevant to NGF mitogenic activity. 
Whether p75 exerts any effects on the cell surface NGF binding 
characteristics or at the post-receptor level remains, however, an 
open question. The concentrations of NGF effective in exerting a 
proliferative action on keratinocytes are relatively higher than those 
exerting differentiative effects on neuronal or PC12 cells expressing 
both NGF-R classes. Possible explanations may include differences 
per se in the sensitivity of cells to the differentiative versus prolifer-
ative action ofNGF, differences in the amount or splicing processes 
of one or the other NGF-R species, and/or cellular shedding of 
soluble p75 forms keeping NGF in solution [48]. In addition, EGF is 
routinely added to our culture medium, and its presence may con-
ceivably explain the high doses ofNGF needed to stimulate kerati-
nocyte proliferation, perhaps competing with the NGF mitogenic 
effect. Indeed, EGF is a potent mitogen for keratinocyte and, like 
NGF, acts via a receptor that possesses an intracellular tyrosine 
kinase domain [46]. Preliminary data indicate that, without EGF, 
NGF, at doses as low as 10 ng/ml, is able to induce keratinocyte 
proliferation (data not shown) . 
The experiments described here show furthermore that cultured 
normal human keratinocytes synthesize and secrete NGF. These 
data confirm the work of others with both human [21] and murine 
keratinocytes [49], although the present report is the first to quanti-
tate by a sensitive ELISA method the amounts ofNGF released. The 
in vitro bioassays for NGF employed in earlier studies do not allow, 
unfortunately, a precise comparison with our data. The present 
study also demonstrates that keratinocytes secrete greater amounts 
of NGF when sub confluent as compared to confluent and more 
differentiated cells, suggesting that NGF secretion is growth-regu-
lated, in agreement with the study ofDi Marco and co-workers [21]. 
This finding and the proliferative activity ofNGF seems to suggest 
an autocrine role of NGF in human epidermis, and a possible in-
volvement of this molecule in certain physiopathologic cutaneous 
conditions. For instance, NGF has been shown to accelerate wound 
healing in mice [50] . This beneficial effect could reflect not only 
keratinocyte hyperproliferation but also a trophic activity of NGF 
on sensory neurons, intensely re-innervating the skin during wound 
healing. 
Conceivably, NGF could also be involved in disorders ofkerati-
nocyte proliferation such as psoriasis, the latter being characterized 
by keratinocyte hyperproliferation, inflammatory cell infiltration, 
and alteration of certain cytokines [51]. In addition to its growth-
promoting activity on keratinocytes, NGF is also reported to acti-
vate mast cells and T lymphocytes [3,7], which invade the psoriatic 
lesion [52]. Interleukin-6, which is expressed in high levels in psori-
atic skin and which stimulates proliferation of human keratinocytes 
[53], can enhance NGF secretion [54]. Interestingly, agents used in 
the treatment of psoriasis , e.g., UVB [49], steroids [21], and retinoic 
acid [55], modulate NGF expression. 
Immunohistochemical studies have shown a consistent correla-
tion between NGF-R expression on keratinocytes and the presence 
of intraepidermal sensory nerves [56] . Moreover, sensory fibers co-
expressing NGF-R and neuropeptide immunoreactivity are seen in 
close proximity to the basal epidermal cells [23]. As NGF can regu-
late the expression of neuropeptides in sensory neurons [57,58], 
perhaps there exists a functional interrelationship between peptid-
ergic sensory neurons, neuropeptides, and NGF at the skin level. 
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Further work will be required to better understand the role of 
NGF in normal as well as pathologic conditions in the skin. Human 
keratinocytes in culture should provide a useful model to study these 
NGF effects in vitro. 
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